Variant · Snv
BCKDHA NM_000709.4(BCKDHA):c.484+5G>A
CI-VAR-00018124Explore in graph →NM_000709.4:c.484+5G>AClinVar 93362 rs149899007
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 93362 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Maple syrup urine disease; Maple syrup urine disease type 1A; BCKDHA-related disorder; Adrenocortical carcinoma, hereditary; Cervical cancer; Familial cancer of breast; Acute myeloid leukemia; Nonpapillary renal cell carcinoma | germline | 8 | Feb 01, 2026 | clinvar |